Sangamo Therapeutics Announces Participation at Jefferies Healthcare Conference

BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 4th at 11am Eastern Time. The virtual session will be webcast live and may be accessed on the Sangamo Therapeutics website...

Click to view original post